|
![]() |
|||
|
||||
OverviewAcross the world, different diseases have been treated with herbal extracts, based on common and empiric knowledge. The process of identification of the active compounds and their synthesis, optimisation and development for new drug candidates appropriate for clinical use is described as Medicinal Chemistry; a discipline merging chemistry and pharmacology. This monograph describes a group of active ingredients from herbal medicines, as a foundation for the development of new anticancer drugs. Interactions between with genomic DNA, synthetic polynucleotides and higher order DNA isoforms (triple and quadruple helical forms) have been studied. Rational drug design has been also employed during this project to elucidate the mode of binding and novel compounds have been synthesized to provide precise structure-activity related studies resulting in a second generation of chemotherapeutic anticancer agents with improved properties. This book provides information and protocols for studying drug-DNA interactions using spectroscopical and biological techniques; synthesis of flavonoids and the principles to explore the use of Quantitative Structure Activity Relationship Studies. Full Product DetailsAuthor: Patricia RagazzonPublisher: VDM Verlag Dr. Muller Aktiengesellschaft & Co. KG Imprint: VDM Verlag Dr. Muller Aktiengesellschaft & Co. KG Dimensions: Width: 15.20cm , Height: 1.50cm , Length: 22.90cm Weight: 0.387kg ISBN: 9783639157673ISBN 10: 3639157672 Pages: 260 Publication Date: 21 May 2009 Audience: General/trade , General Format: Paperback Publisher's Status: Active Availability: In Print ![]() This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us. Table of ContentsReviewsAuthor InformationTab Content 6Author Website:Countries AvailableAll regions |